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INCE the advent of major abdomina1 
surgery the probIem of postoperative 
peritonitis has been an extremeIy 
important one and stiI1 presents itseIf as a 
chaIIenge to the surgeon from the stand- 
point of both prevention and cure. During 
the past fifty years there has been a Iarge 
amount of work done on the production of 
peritonitis in various experimenta animaIs, 
and attempts have been made to correIate 
the findings in animaIs with the peritonitis 
which occurs in the human being. Such 
attempts have been far from satisfactory 
and there is stiI1 need for more carefuIIy 
controIIed Iaboratory and cIinica1 investiga- 
tion in the fieId. 
The earIy workers on experimenta 
peritonitis found it diffrcuIt to produce a 
true fibrinopurulent peritonitis by the 
intraperitonea1 injection of bacteria. They 
couId eariIy produce a bacteremia, or, with 
more viruIent organisms, couId get a IethaI 
effect, but not a peritonea1 exudate. It 
therefore occurred to them that peritonitis 
per se was probabIy not the cause of death, 
but was in reaIity a protective mecha- 
nism, and that the animaIs, paradoxicaIIy 
enough, died from a want of inflammatory 
reaction rather than as a resuIt of it. 
Herrman, in 1927, at the Mayo CIinic, 
showed that in order to produce a peri- 
tonea exudate in the rabbit it was first 
necessary to buiId up an immunity before 
injecting the infecting materia1. This was 
successfuIIy carried out by using repeated 
smaI1 intraperitonea1 doses of a vaccine 
prepared from the coIon baciIIus and 
Streptococcus viridans. At autopsy the 
animaIs showed a true fibrinopuruIent 
peritonitis, but contro1 animaIs which 
received no such immunizing vaccine died 
promptIy with no visibIe evidence of 
peritonitis. Today, this concept regarding 
the production of peritonitis is generaIIy 
accepted, and comes to our attention every 
time we perform an abdomina1 operation. 
We know that the degree of resistance of 
the peritoneum wiI1 vary with the extent to 
which the peritoneum has been previously 
immunized. In cases of regressing acute 
choIecystitis, in which pus is spiIIed into the 
peritonea1 cavity at operation, there is no 
grave danger from a subsequent severe 
peritonitis. This resistance of the peri- 
toneum to a limited amount of infection is 
probabIy not due to any “natura1” or 
“inherent” immune quaIity, but is more 
IikeIy the resuIt of an exceIIent bIood and 
Iymphatic suppiy. 
Attempts to immunize the peritoneum 
by the intraperitonea1 injection of vaccines 
and various foreign substances are by no 
means new. As earIy as 1887 PawIowsky 
used croton oi1 to produce peritonitis in 
experimenta animals. The probIem was 
more activeIy studied by Issaef in 1894 
when he introduced the idea of vaccina- 
tion to prevent postoperative peritonitis. 
PierraIini, in 1897, found that a Ieucocytic 
exudate couId be produced by the intra- 
peritonea1 injection of sodium chloride and 
other inert substances. In the same year 
GarniCr demonstrated that bacteria were 
rapidIy destroyed in the presence of such a 
Ieucocytic exudate in the peritoneal cavity, 
and his researches reveaIed a new concept 
regarding the mechanism of protection 
from an otherwise fatal peritonitis, nameIy 
phagocytosis. In 1902, Soheri, working on 
the theory that “immunity” was a resuIt 
of phagocytosis, produced a peritonea1 
Ieucocytic exudate, and found that animaIs 
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with such an inffammatory reaction of 
the peritoneum survived a coIon baciIIus 
peritonitis. 
The probIem of peritonea1 immunization 
was reopened in this country by Steinberg 
and GoIdbIatt in 1926, and since then they, 
working together and individuaIIy, have 
done a Iarge amount of research on this 
phase of peritonitis. Their earIier experi- 
ments showed that intraperitonea1 im- 
munization by living and heat-kiIIed coIon 
baciIIi produced an immunity to sub- 
sequent coIon baciIIus and feca1 peritonitis. 
Later, in a series of experiments in which 
they studied the cause of death in peritoni- 
tis, they presented convincing evidence 
concerning the rate of passage of bacteria 
from the peritonea1 cavity into the Iymph 
and bIood streams. Working with dogs, 
they found that when coIon baciIIi in saIine 
suspension were injected intraperitoneaIIy 
they were rapidIy absorbed into the bIood 
and Iymph, and that such animaIs prac- 
ticaIIy aIways survived. However, when 
equa1 doses of the coIon baciIIus were 
suspended in I per cent gum tragacanth, 
the animaIs did not get a bacteremia, but 
invariabIy diet. The hypothesis was there- 
fore formuIated that toxic products of the 
bacteria were formed in quantity onIy 
when they were retained within the peri- 
tonea cavity, and that such toxic products 
were the cause of the death of the anima1. 
ConcurrentIy, David and Sparks, in 
1927, threw further Iight on the mechanism 
of absorption of bacteria, and heIped to 
estabIish the beIief that peritonitis serves a 
protective function. They showed in ani- 
maIs that when coIon baciIIi were injected 
intraperitoneaIIy they passed readiIy into 
the bIood and Iymph. When, however, a 
pIastic peritonitis was first produced by 
injection of a turpentine em&ion, organ- 
isms subsequentIy injected intraperito- 
neaIIy couId not be recovered from the 
bIood stream or thoracic duct. 
PeritoneaI “immunity,” so-caIIed, is 
probabIy not a true immunity but a IocaI 
form of protection which manifests itseIf as 
a reaction of the peritoneum to trauma and 
infection. In this connection, most students 
of peritonitis fee1 that phagocytosis pIays 
an important protective rBIe. There is, 
however, no uniformity of opinion regard- 
ing the relative protective functions of the 
poIymorphonucIear Ieucocytes and the 
Iarge mononucIear ceIIs or histiocytes. 
Since his earIiest studies, Steinberg has 
contended that the protection secured 
from intraperitonea1 vaccination is a resuIt 
of phagocytosis of otherwise harmfu1 bac- 
teria. He regards the poIymorphonucIear 
Ieucocyte as the important ceI1 serving in 
this capacity, and has designated this type 
of protection “ hyperIeucocytic pre-immu- 
nity.” He feels that the histiocyte is a 
“scavenger” ceI1 which appears reIativeIy 
Iate in peritonitis, where it can be demon- 
strated to enguIf degenerated poIymorpho- 
nucIears in this stage of the disease. He has 
emphasized the point that the poIymorpho- 
nucIear ceIIs act earIy in carrying out their 
phagocytic function. 
At the Mayo CIinic the opinion has 
prevaiIed among the various workers that 
the histiocyte is probabIy the most impor- 
tant ceI1 concerned with phagocytosis. 
Hermann earIy expressed this belief in his 
work on rabbits and since then it has been 
supported by other investigators. In 1933, 
an interesting study on the peritonea1 fluid 
of man was carried out by Rixford. He had 
an opportunity to study the peritonea1 
Auid in patients at operation which had 
previousIy received intraperitonea1 vaccine, 
and to compare these findings with a 
contro1 group of patients which had re- 
ceived no vaccine. Specimens were taken 
with a gIass pipette just after the peritonea1 
cavity was opened. In unvaccinated cases, 
the tota white ceI1 count averaged from 
1,900 to 2,600 per c. mm. of fluid. There 
were practicaIIy no neutrophiIes, very few 
eosinophiIes and basophiIes, but many 
Iymphocytes and histiocytes (45 per cent). 
In patients who had been vaccinated 24 to 
144 hours prior to operation, specimens of 
peritonea1 Auid were aIso examined. There 
was considerabIe variation in the findings, 
but it was apparent that there was an earIy 
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increase in poIymorphonucIear ceIIs and a 
deIayed but nevertheIess marked increase 
in histiocytes. 
The ceI1 counts of the total peritonea1 
fluid have been carefuIIy made by SeeIey, 
Higgins, and Mann. Working with rats, 
they used various substances to evoke a 
peritonea1 reaction, and then removed and 
weighed a11 the fluid present, in addition to 
making differentia1 ceI1 counts. FoIIowing 
injections of amniotic Auid concentrate, 
Bargen’s vaccine (prepared from coIon 
baciIIi and nonhemoIytic streptococci) and 
sodium ricinoIeate, they found that with 
a11 materiaIs there was an earIy and rapid 
rise of poIymorphonucIears, reaching a 
maximum in three to six hours. Histiocytes 
appeared much Iater, but, were the pre- 
ponderant ceIIs after six or seven days. The 
response of both ceIIs was greater in those 
animaIs receiving sodium ricinoIeate. 
In 1937, Corwin, working with rabbits, 
reported that the ceIIuIar responses to 
Bargen’s vaccine and sodium ricinoIeate 
were nearIy identical quaIitativeIy. The 
intervaIs for maxima1 ceIIuIar reactions 
varied, however. With Bargen’s vaccine, 
the ceI1 count of the peritonea1 Auid was 
greatest at tweIve hours, with I per cent 
sodium ricinoIeate at twenty-four hours, 
and with 2 per cent sodium ricinoIeate at 
forty-eight hours. The differentia1 count 
again showed that poIymorphonucIears 
appeared earIy, being in greatest abun- 
dance in six to twelve hours, whiIe the 
histiocytes were maxima1 in one to three 
days. 
It is apparent from the above studies 
that variation in opinion regarding the reIa- 
tive phagocytic properties of the neutro- 
phiIes and histiocytes is due in part to the 
use of different species of animaIs by vari- 
ous workers. The type of materia1 used to 
evoke a reaction, the dosage empIoyed, 
and the time intervals for examination of 
the fluid are aIso inconstant factors which 
must be evaIuated in arriving at a definite 
conclusion. 
In order to prove or disprove the value 
of any of the numerous agents that have 
been used to immunize the peritoneum, it 
wouId be necessary to use such an agent 
in a very Iarge series of patients having 
major abdomina1 operations, and at the 
same time have an equaIIy Iarge number of 
simiIar cases as a contro1 group. As yet no 
such investigation has been reported. How- 
ever, during the past ten years there are 
three immunizing agents which have beefi 
empIoyed more extensiveIy than numerous 
other substances. These are (I) the vaccine 
deveIoped by Steinberg and GoIdbIatt, 
(2) the vaccine prepared by Bargen, and 
(3) the amniotic ffuid preparations origi- 
naIIy suggested by Johnson. 
Steinberg and GoIdbIatt, working on the 
idea that a marked Ieucocytic reaction in 
the peritonea1 cavity couId be more easiIy 
produced by some agent which prevented a 
rapid absorption of bacteria, deveIoped a 
protective emuIsion which they have caIIed 
coIi-bactragen. This preparation has since 
been modified by Steinberg, and his 
formuIa for the more recent preparation is 
as foIIows : 
Tragacanth. . . I .5 Gm. 
Aleuronat. . . . . . . 0.5 Gm. 
Escherichia coIi (30 c.c.) . 2,400,000,000 
SaIt sotution 60.85 per cent I00 c.c. 
Today there is ampIe evidence that this 
emulsion wiI1 protect the experimental 
anima1 from certain types of subsequentIy 
induced peritonitis. Steinberg has suc- 
ceeded in demonstrating protection against 
Iiving colon baciIIi, streptococcus fecalis, 
B. pyocyaneus, and clostridia weIchi, in 
both pure and mixed cuItures. 
In the coIIected series of 400 patients 
receiving coIi-bactragen which were re- 
ported by GoIdbIatt in 1934, eight post- 
operative deaths were recorded, but only 
three of these couId be attributed to 
peritonitis. In the majority of patients who 
were operated upon by various surgeons, a 
resection of a part of the Iarge bowe1 was 
performed. The preparation employed was 
injected intraperitoneaIIy about forty-eight 
hours before Iaparotomy was performed 
and was frequentIy accompanied by a 
rather severe genera1 reaction. The patient 
64 American Journal of Surgery CoIIer, Rife-Immunization OCTOBER, t 939 
was occasionaIIy so sick from the vaccina- 
tion that operation was necessariIy post- 
poned. The series was too smaI1, however, 
to permit any concIusions regarding the 
efficacy of the vaccine. The more recent 
preparation of coIi-bactragen is an im- 
provement over the former one, not onIy in 
that it produces a Iess severe genera1 
reaction, but has the additiona advantage 
of achieving its maximum protection within 
a few hours, thereby permitting its being 
introduced at the time of operation. 
Steinberg has found that the period of 
maximum protection is shortened by using 
formaIdehyde rather than heat to kiI1 the 
coIon baciIIi. 
In 1935, Potter and CoIIer reported their 
resuIts on a series of patients who were 
given coIi-bactragen prior to operation. In 
seventy-nine patients, most of whom re- 
quired major operations upon the coIon, 
there were eIeven deaths, but in onIy one 
couId the fata outcome be definiteIy 
attributed to peritonitis. They noted that 
the peritonea1 reaction varied from a miId 
hyperemia to an abundant exudate re- 
sembIing that of a fibrinopuruIent peritoni- 
tis. AIthough the series of cases was too 
smaI1 to permit definite concIusions, they 
were of the opinion that the vaIue of the 
vaccine was questionabIe except in cases of 
gross feca1 contamination. In 1936, CoIIer 
and Ransom reported the use of coIi- 
bactragen in seventy-nine cases which had 
a combined abdominoperinea1 resection for 
carcinoma of the rectum and rectosigmoid. 
There were tweIve deaths, but in none 
couId death be proved to be the resuIts of 
peritonitis. In the same year Steinberg 
reported 391 cases in which coIi-bactragen 
was used preoperativeIy or at the time of 
operation, with none deveIoping postopera- 
tive peritonitis. 
In 1928, at the Mayo CIinic, based on 
experimenta work done by Herrmann, 
Bargen deveIoped a vaccine prepared from 
streptococci and coIon baciIIi. The vaccine 
was given three days before operation 
invoIving intestina1 resections. In 1935 
Dixon and BarEen reDorted havine: used the 
vaccine in 1,500 such cases, with a reduc- 
tion of 66 per cent in the mortaIity rate 
from postoperative peritonitis. The reac- 
tion from the vaccine usuaIIy consisted in a 
temperature eIevation to 102O or 103%. 
which receded in a gyrate fashion and 
returned to norma twenty-four to thirty- 
six hours after vaccination. In 1930, 
Rankin, in a review of 527 surgica1 Iesions 
of the Iarge intestine and rectum in which 
peritonea1 vaccination was used preopera- 
tiveIy, reported a mortaIity rate of 12.3 
per cent by patient and 8.6 per cent by 
operation. In 1933, he began a new series of 
operations upon organic Iesions of the coIon 
and rectum in which the vaccine was not 
used. In 200 consecutive operations upon 
130 patients he reported a mortaIity rate 
of 5.5 per cent by operation and 8.4 per cent 
by operation. Rankin has attributed the 
decIine in mortaIity to better preoperative 
preparation rather than to vaccination. 
Johnson, in 1922, first conceived the 
idea of using amniotic ffuid to prevent 
postoperative adhesions, and since then he 
has used it as an agent to assist in the 
processes of peritonea1 defense and repair. 
WhiIe the use of a substance which aI- 
IegedIy prevents adhesion formation but 
at the same time protects against peritoni- 
tis seems paradoxica1, Johnson expIains 
that the action of amniotic fluid on the 
peritoneum is to produced a protective 
Iayer of fibrin on the serous surfaces and a 
moderate IocaI Ieucocytosis, which is foI- 
Iowed Iater by a compIete resoIution of the 
fibrinous deposit. The amniotic fluid used 
is obtained from cows two to five months 
pregnant. It is steriIized by the BerkfeId 
flter method. Johnson is of the opinion that 
amniotic fluid provokes a peritonea1 reac- 
tion which is entireIv within the Iimits of 
” 
safety, gives an earIy response, and pro- 
duces onIv a minimum ohvsioIo&c disturb- ., I u 
ante. He describes the periton&I reaction 
as a “defense response characterized by 
hyperemia, marked subserous edema, in- 
crease in peritonea1 fluid, and the forma- 
tion of a pink-tinged fibrinous exudate. 
There is an increased white ceII count 
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which rises rapidIy for about tweIve hours, 
at which time the differentia1 count shows 
a marked preponderance of poIymorpho- 
nuclear Ieucocytes. Having reached its 
peak, the white ceI1 content of the exudate 
graduaIIy recedes and the neutrophiIes are 
repIaced by the histiocytes. The tota 
white ceI1 count finaIIy becomss preponder- 
antIy histiocytic.” He states that when the 
exudate is removed from the peritonea1 
cavity it quickIy forms a fibrin cIot. By 
contrast he points out that foIIowing the 
intraperitonea1 injection of vaccines there 
is a very severe reaction characterized by 
a profuse hemorrhagic exudate which does 
not cIot upon remova and exposure to 
air. 
Johnson’s work has been coIIaborated in 
by Warren, TrusIer, Young and Marks, 
Kimpton and others. In 1934, Young and 
Marks reported on the use of amniotic 
Auid concentrate in forty-nine cases which 
invoIved, for the most part, operations on 
the Iarge intestine. There were three deaths, 
but in onIy one instance could death be 
attributed to postoperative peritonitis. In a 
series of forty-six simiIar cases in which 
amniotic Auid was not used preoperativeIy 
they reported eight deaths, or a mortaIity 
of 17.3 per cent, from postoperative peri- 
tonitis. In the Iatter group, when they 
incIuded onIy the cases in which the bowe1 
was resected, there was a mortaIity of 
38 per cent. In 1936, Gepfert reported on 
the use of concentrated fractions of bovine 
amniotic Auid (amfetin, LiIIy). He was of 
the opinion that patients receiving amni- 
otic Auid had a smoother postoperative 
course than did a simiIar group of contro1 
patients. 
Further studies in nonspecific peritonea1 
immunization were reported by Morton in 
193’. He used various substances to 
vaccinate the peritoneum, particuIarIy 
dextrose broth, heated streptococcus fiI- 
trate, various soIutions of glucose, and 
sodium chIoride. Using rabbits, he found 
that he was abIe to estabIish a certain 
degree of protection in most of the animaIs 
at the end of sixty hours, and, at the end of 
severa days, “immunity was proved in 
I00 per cent.” 
The use of bacteriophage has given a 
variety of resuIts, both experimentalIy and 
cIinicaIIy. Rice gave a negative report of 
his work on IocaI immunization by the use 
of bacteriophage in 1933. Immunization 
of the peritoneum of dogs was attempted 
by injecting intraperitoneaIIy a mixture 
of staphyIococcus, streptococcus, and B. 
coIi bacteriophage filtrates. The animaIs 
were given bacteriophage before or at the 
time of_operation, which consisted in tying 
off the cecum in order to produce peritoni- 
tis. Under the conditions of the experi- 
ments, it was found that the bacteriophage 
faiIed to immunize the peritoneum. More- 
over, it seemed to inhibit the formation of 
pIastic exudates when used before or during 
operation. Rice expressed the opinion, 
however, on the basis of previous cIinica1 
experience, that bacteriophage was of vaIue 
in treating abscesses which were we11 
waIIed off. 
Jern, Harvey, and MeIeney, working 
with mice, reported in 1932 on their use of 
bacteriophage to protect against coIon 
baciIIus peritonitis. They found that they 
were abIe to protect the animaIs against 
such an infection, even when they used 
doses twenty-five times the IethaI dose for 
norma controIs. The phage was effective 
when used intraperitoneaIIy before, during, 
or even severa hours after the injection 
of the colon baciIIi. 
It is apparent that numerous diffrcuIties 
are encountered when one studies the 
probIems connected with the use of bac- 
teriophage. There is a marked difference in 
the susceptibiIity of various strains of the 
coIon baciIIus to Iysis by bacteriophages. 
Against the streptococcus, which is prob- 
abIy the second most common, and one of 
the most viruIent, organisms causing peri- 
tonitis, there are few active bacteriophages. 
Moreover, the behavior of a bacteriophage 
is unpredictabIe; it may fai1 to cause Iysis of 
a particuIar strain of organisms but at the 
same time be effective in causing Iysis of 
unreIated bacteria. At present it cannot be 
said that there is sufficient cIinica1 evidence If patients are properIy prepared for 
to prove the vaIue of any of the singIe or operation, and if the operation is carried 
combined bacteriophages, but there are out with carefu1 meticuIous technique, 
sporadic reports of success in treating a peritonitis rareIy supervenes. We do fee1 
reIativeIy smaI1 number of peritonitis. that the use of some substance that wiI1 
FiItrates have been used severa years to produce rapid IocaI Ieucocytic response is of 
immunize the peritoneum, but up to the vaIue in those instances in which, because 
present time there is very IittIe evidence, of accident &of operation or disease, the 
either experimenta or cIinica1, to indicate Iarge bowe1 is opened. Our own experience 
that they are of vaIue. Further work wiI1 be in these circumstances has been most 
necessary to eIucidate regarding their extensive and most satisfactory with coIi- 
present contradictory status. bactragen (Steinberg). We fee1 that it has a 
In spite of the fact that there has been a distinct vaIue when used in the con- 
Iarge amount of thorough experimenta taminated stage, and that it has IittIe or no 
work on the immunization of the peri- vaIue once the infected stage is estabIished. 
toneum, there stiI1 remains a wide gap to Postoperative peritonitis in cIean cases is 
be fiIIed if our experimenta knowIedge is to usuaIIy due to errors of operative technique 
be appIied to the human being. Such factors that cannot be corrected by the introduc- 
as the species of Iaboratory anima1 used, tion into the peritoneum of anything except 
type and dose of immunizing substance better surgery. 
empIoyed, and the time and mode of its 
administration, make it diffIcuIt to compare 
the findings of one investigator with those 
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